Gene engineering, CRISPR, precision medicine, longevity science, drug discovery
Researchers at MIT and Microsoft have leveraged AI to design molecular sensors for early cancer detection, while other MIT teams have developed methods to rejuvenate aging immune systems and create instant 3D structures from flat sheets.
Williams·
Today's analysis of 154 papers marks a shift from semantic fluency to 'Verifiable Agency.' OpenEarthAgent and KLong highlight breakthroughs in geospatial tool-use and long-horizon tasks. However, a 'Medical Reality Check' reveals that while specialized models excel, generalist MLLMs fail critically on benchmarks like MediConfusion and clinical tasks like Cobb angle measurement. Additionally, AutoNumerics introduces autonomous, transparent design of PDE solvers.
Jason·
Neuralink has launched Phase II of its human trials, enabling a subject to control a robotic exoskeleton via thought alone. This milestone shifts BCI technology from digital communication to physical mobility restoration, while sparking intense legal debates over 'Neurorights.'
Jason·